Minister urged to block takeover of inhaler manufacturer by tobacco firm

摘要

Professional groups, including the Royal Pharmaceutical Society (RPS), have urged the government to oppose the takeover of an asthma inhaler manufacturer by a tobacco firm. In a letter to Lord Bethel, the parliamentary under-secretary of state for innovation, the RPS expressed its ethical concerns about the proposed takeover of Vectura-a UK company that makes products used in the treatment of asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases-by the tobacco company Philip Morris International.